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Aim: To evaluate the prevalence of nocturia among different degrees of obstructive sleep apnea (OSA) and its association with various
clinical conditions.
Materials and methods: In 730 OSA patients, the prevalence and frequency of nocturia was determined, and the association of nocturia
with clinical and laboratory variables such as the apnea–hypopnea index (AHI), apnea duration, and minimum oxygen saturation
and clinical conditions such as diabetes mellitus, coronary heart disease, and chronic obstructive pulmonary disease (COPD) was
determined.
Results: The overall prevalence of nocturia (≥2 wakes/night) was 50.9%. Prevalences of nocturia in simple snoring and mild, moderate,
and severe OSA patients were 40.6%, 44.4%, 58.6%, and 57.1%, respectively (P < 0.005). The frequency of nocturia significantly increases
with the severity of OSA (1.4 ± 1.0 wakes/night in mild OSA vs. 2.0 ± 1.4 wakes/night in severe OSA, P = 0.001). Age, AHI, average
oxygen saturation, and presence of diabetes mellitus, hypertension, and COPD were found to be significant risk factors associated with
nocturia (P < 0.001).
Conclusion: The frequency of nocturia increases as the severity of OSA increase. The increased prevalence of nocturia in patients
with OSA, diabetes mellitus, hypertension, and COPD indicates the complex physiological background of this bothersome urologic
symptom.
Key words: Sleep, apnea, nocturia

1. Introduction
Obstructive sleep apnea (OSA) is a disorder characterized
by repetitive, complete, or partial obstruction of the upper
airways, and it is usually associated with a reduction
in blood oxygen saturation. Major symptoms, namely
snoring, witnessed apnea, and excessive daytime sleepiness,
are sometimes accompanied by minor symptoms such as
sweating, dry mouth, headache, and intellectual disorders
(1).
Nocturia, which is defined as waking to pass urine
after falling asleep at night, is not uncommon in patients
with OSA. In 2002, the International Continence Society
defined nocturia as waking at night to void. This definition
covers any number of voids in which patients wake up
from sleep (2). It is one of the most common reasons for
sleep interruption in the adult population of both sexes.
The incidence of nocturia increases with age (3,4). The
etiology of nocturia is complex, but the symptom results
* Correspondence: sibeloktem2000@gmail.com

from any of the following conditions: diurnal polyuria,
nocturnal polyuria, and low bladder capacity. Nocturia
is also found to be associated with aging, overactive
bladder, benign prostatic obstruction in men, medications
(diuretics, analgesics), or chronic clinical conditions such
as diabetes mellitus, diabetes insipidus, anorexia nervosa,
congestive heart failure causing peripheral edema, and
sleep disturbances (5).
The prevalence of nocturia in OSA patients ranges
between 48% and 76% depending on the number of
night time voids accepted to be pathologic (6–8). It has
been shown that the frequency of nocturia in patients
with OSA is significantly higher than in healthy controls
(9,10). Moreover, it has been shown that as the severity
of OSA increases, the frequency of nocturia increases, as
well (6,8). Interestingly, the frequency of nocturia tends
to decrease when OSA is treated with continuous positive
airway pressure (11,12).
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It seems that there is an association between upper
airway obstruction and nocturia. In this large retrospective
series we searched for the fundamentals of this
association. In our work we evaluated the prevalence of
nocturia among patients suffering from different degrees
of OSA and the association of nocturia with laboratory
parameters recorded during polysomnography (PSG). We
also evaluated the association of nocturia with chronic
clinical conditions such as diabetes mellitus, hypertension,
chronic obstructive pulmonary disease (COPD), and
coronary heart disease.
2. Materials and methods
We retrospectively evaluated the polysomnographic
recordings of 730 patients (256 females, 474 males) who
were referred to our sleep center with the suspected
diagnosis of OSA. The age of the patients ranged between
19 and 80 years. All patients completed a patient evaluation
questionnaire before PSG, which was carried out with the
Alice 5 Diagnostic Sleep System set (version 2007, Philips
Respironics) in the sleep laboratory, and a single overnight
PSG result was obtained for each patient.
2.1. Patient exclusion criteria and Epworth Sleepiness
Scale
Patients with known benign prostate hyperplasia; patients
with uncontrollable or poorly controlled congestive heart
failure, diabetes mellitus, chronic renal failure, COPD, or
hypertension; patients with drug or alcohol addiction; and
patients diagnosed to have other types of sleep disorders
such as restless leg syndrome, periodic leg movements in
sleep, REM disturbances, and central sleep apnea were
excluded from the study.
Daytime sleepiness of the patients was evaluated
by Epworth Sleepiness Scale (ESS). The ESS is a brief
questionnaire that subjectively measures an individual’s
likelihood of falling asleep in real life situations such as
sitting, reading, watching TV, or driving. Scores range
from 0 to 24, where higher scores correlate with increased
sleepiness. When used as a screening tool, scores over 8
indicate the need for a consultation from a sleep specialist.
2.2. Evaluation of nocturia
Nocturia was evaluated by 2 questions: “During the past
5 days, did you wake up to void at night after you fell
asleep?” and “During the past 5 days, how many times did
you wake up to urinate at night after you fell asleep?”
2.3. Polysomnography
PSG was carried out with the Alice 5 Diagnostic
Sleep System set (version 2007, Phillips Respironics).
During PSG, recordings of central and occipital
electroencephalography, submental electromyography
(EMG), bilateral electrooculogram, airflow, patient
position, bilateral anterior tibial EMG, electrocardiogram,
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respiratory efforts, pulse oximeter, and video
monitorization of the patients were obtained. Patients
entered the test room at 2000 hours. The lights were turned
off at 2200 hours and recordings began. Polysomnograms
were performed and reported by a certified specialist who
was one of the coauthors of this article (SA). Sleep stages
were classified according to the criteria of Rechtschaffen
and Kales (13). Respiratory parameters of the patients
were classified according to criteria set by the American
Academy of Sleep Medicine. Complete secession of
oronasal air flow for longer than 10 s was defined as an
apnea. A decrease in oxygen saturation by 3% for a period
of longer than 10 s or arousal with a 50% decrease in
oronasal airflow was defined as hypopnea. The number of
apneas and hypopneas recorded in 1 h was defined as the
apnea–hypopnea index (AHI) (14).
The severity of OSA was graded as follows:
Patients with an AHI score of <5 were labeled as having
simple snoring (normal), patients with an AHI score
between 5 and 15 were diagnosed with mild OSA, patients
with an AHI value between 15 and 30 were diagnosed with
moderate OSA, and patients with an AHI value of ≥30
were diagnosed with severe OSA (15).
The following variables were evaluated for their
association with the frequency of nocturia:
• Demographic variables such as age, sex, body
mass index, neck circumference, and comorbid
conditions such as diabetes mellitus, hypertension,
coronary heart disease, and chronic pulmonary
lung disease;
• Score on the ESS;
• Polysomnographic parameters such as AHI,
minimum saturation, mean saturation, and longest
apnea duration.
2.4. Statistical analysis
The mean, median, and standard deviation were used
in the descriptive analysis of the variables. Analysis of
variance was used in the multiple group comparisons of
continuous variables. The Tukey test was used in the post
hoc analysis. The chi-square test was used to compare
frequencies of variables between groups. Multiple logistic
regression analysis within a confidence interval of 95% was
performed to estimate the relative risk of factors affecting
nocturia frequency. P-values of less than 0.05 were
accepted as having statistical significance. All calculations
were performed by SPSS 11.0.
3. Results
There were 160 (22%) patients who had simple snoring.
There were 160 (22%) patients with mild OSA, 128
(17.5%) with moderate OSA, and 282 (38.5%) with severe
OSA. The percentage of patients having nocturia ≥2 times
per night was similar in male and female patient groups
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(51.3% vs. 50.4%). Patients with simple snoring were
found to be younger, and female patients predominated in
this group. These patients had smaller body mass indexes
and narrower neck circumferences. Patients in the mild,
moderate, and severe OSA groups were older and had more
comorbidities when compared to patients in the simple
snoring group. Patients with severe OSA were mostly
male, were older, and had greater neck circumferences and
body mass indexes and increased Epworth scale values.
Table 1 shows the demographic characteristics (age, sex,
body mass index, and neck circumference) and comorbid
conditions of patients grouped according to OSA severity.
Seventy-five patients (10.3%) did not report any
nocturia in their patient evaluation form. The percentage
of patients who reported 1, 2, 3, and ≥4 nocturia episodes
per night were 38.8%, 27.3%, 13.8%, and 9.9%, respectively
(Table 2). The frequency of nocturia significantly increased
as the severity of OSA increased (1.4 ± 1.0 wakes/night in
mild OSA vs. 2.0 ± 1.4 wakes/night in severe OSA, P =
0.001). A statistically significant majority of patients with
≥4 nocturia episodes were in the severe OSA group (39 of
72 patients, 54.2%; Pearson chi-square, P < 0.001). Most of
the patients who did not report any nocturia were in the
simple snoring and mild OSA groups (45 of 75 patients,
60%). The percentage of patients having any frequency
of nocturia was highest in the moderate and severe OSA
groups, followed by the mild OSA and simple snoring
groups (93.8% and 92.2% vs. 85% and 87%, respectively;
Pearson chi-square, P < 0.005; Table 2). When patients

were further grouped as having nocturia frequency of less
than and more than 2 episodes per night, the percentage
of patients with 2 or more nocturia episodes was 50.9%.
(40.6% in the simple snoring group, 44.4% in the mild
OSA group, 58.6% in the moderate OSA group, and 57.1%
in the severe OSA group) (Pearson chi-square, P < 0.001;
Table 2).
The frequency of OSA and nocturia both increased
significantly as age increased. Figures 1 and 2 show the age
group distribution of OSA severity and nocturia frequency.
The percentages of hypertension (65.5%), diabetes
mellitus (70.3%), coronary artery disease (68.3%), and
COPD (77.8%) were significantly higher among patients
with nocturia ≥2 times per night.
In a multivariate logistic regression analysis we found
that age, AHI, average oxygen saturation, and presence
of diabetes mellitus, hypertension, and COPD had a
significant effect on the frequency of nocturia. Relative
risk ratios and confidence intervals of these variables are
shown in Table 3.
4. Discussion
Nocturia is one of the most bothersome urinary tract
symptoms, and it has a negative impact on both sleep
quality and health-related quality of life. This urinary tract
symptom is frequently seen in OSA patients. Depending
on the number of night-time voids accepted to be
pathological, the prevalence of nocturia in OSA ranges
between 48% and 76% (6–8). Supporting the previously

Table 1. Clinical and demographical characteristics, nocturia frequency, and comorbid conditions of patients grouped according to
OSA severity.

A (n = 160),
simple snoring

B (n = 160),
mild OSA

C (n = 128),
moderate OSA

D (n = 282),
severe OSA

P

42.8 ± 11.6

50.0 ± 10.9

53.0 ± 15.2

50.5 ± 10.2

<0.005 a

Body mass index, kg/m

28.9 ± 5.2

30.6 ± 4.9

31.0 ± 5.0

33.3 ± 6.1

<0.005 b

ESS

6.38 ± 4.6

7.31 ± 4.8

7.32 ± 4.8

9.7 ± 5.5

<0.005 c

Neck circumference, cm

37.0 ± 3.2

39.6 ± 3.6

40.2 ± 2.9

41.9 ± 3.4

<0.005 d

Nocturia frequency, per night

1.4 ± 1.0

1.6 ± 1.3

1.9 ± 1.2

2.0 ± 1.4

<0.005 e

Sex: female, % (n)

59.4 (95)

36.7 (59)

32.8 (42)

21.3 (60)

0.005 f

COPD, %

2.0

4.1

9.7

5.5

0.03 g

HT, %

7.2

21.6

27.4

25.8

0.001 h

DM, %

3.9

10.1

16.1

12.0

0.008 i

CAD, %

3.3

4.1

7.3

7.6

0.2

Age, years
2

COPD: chronic obstructive pulmonary disease; HT: hypertension; DM: diabetes mellitus; CAD: coronary artery disease.
a: A < B, C, D; b: A < B = C < D; c: A = B = C < D; d: A < B = C < D, e: A < B < C < D; f: D < B = C < A; g. A = B = D < C; h: A < B = C
= D; i: A < B = C = D.
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Table 2. Distribution of nocturia frequency of patients among OSA groups.
Nocturia frequency

A (n = 160),
simple snoring

B (n = 160),
mild OSA

C (n = 128),
moderate OSA

D (n = 282),
severe OSA

n = 730,
total

None, n (%)

21 (28)

24 (32)

8 (10.7)

22 (29.3)

75 (10.3%)

1 per night, n (%)

74 (26.1)

65 (23)

45 (16)

99 (34.9)

283 (38.8%)

2 per night, n (%)

43 (21.6)

37 (18.6)

48 (24.1)

71 (35.7)

199 (27.2%)

3 per night, n (%)

15 (14.9)

20 (19.7)

15 (14.9)

51 (50.5)

101 (13.8%)

≥4 per night, n (%)

7 (9.7)

14 (19.4)

12 (16.7)

39 (54.2)

72 (9.9%)

Any frequency of nocturia

139 (87%)

136 (85%)

120 (93.8%)

260 (92.2%)

655 (90%)

Nocturia ≥2 times per night

65 (40.6%)

71 (44.4%)

75 (58.6%)

161 (57.1%)

372 (60%)

60

<30 years
30-44 years

50

70

Simple snoring

60

Mild OSA

50
40
30

Patients (%)

Patients (%)

45-64 years

Moderate OSA

40

>65 years

30
20

Severe OSA

10

20
10
0

<30 years

30-44 years

45-64 years

0

≥65 years

Figure 1. The distribution of OSA severity among age groups.

None

1 per night 2 per night 3 per night ≥4 per night

Figure 2. The distribution of nocturia frequency among age
groups.

Table 3. Relative risk ratios and confidence intervals of age, AHI, diabetes mellitus, hypertension, COPD, and average oxygen saturation.
Variable

Beta

Odds ratio

95% CI for exp(B)

Significance

Age

0.028

1.028

1.013–1.044

0.000

AHI

0.012

1.012

1.005–1.019

0.000

Average oxygen saturation

0.083

0.921

0.892–0.950

0.000

COPD

1.115

0.328

0.146–0.739

0.007

HT

0.534

0.586

0.389–0.883

0.011

DM

0.081

0.999

0.001–0.130

0.044

reported data, in this study we also found an increased
frequency of nocturia as the severity of OSA increased. We
found that the percentage of nocturic patients was higher
in the moderate and severe OSA groups than in the mild
OSA and simple snoring groups (94% and 92% vs. 85%
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and 87%, respectively; Pearson chi-square, P < 0.005). The
percentage of patients having ≥2 nocturia episodes was
50.9% (40.6% in simple snoring group and 44.4% in the
mild, 58.6% in the moderate, and 57.1% in the severe OSA
groups) (Pearson chi-square, P < 0.001).
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When compared with the literature, these percentages
are very high, and higher nocturia rates in the moderate
OSA group contradict previously reported data from
other authors. A possible explanation for this may derive
from the patient characteristics and study design. It is
well known that the incidence of nocturia increases with
age and it may result from diurnal polyuria, nocturnal
polyuria, or low bladder capacity (5). Since our study
was retrospective in design, the accumulation of elderly
patients in the moderate OSA group or the predominance
of male patients who could have had nocturia as a result
of benign prostate hyperplasia may have contributed
to this increased percentage. Moreover, in the moderate
OSA group, there were more patients with coronary heart
disease, COPD, and hypertension, which might also have
affected the frequency of nocturia.
Although there are controversial results with regard to
male or female predominance in nocturia (6,10,16), in our
study, we found no difference in the prevalence of nocturia
between the sexes.
Several factors have been identified that effect
the frequency of nocturia in OSA patients. Besides
demographic factors such as age, sex, body mass index, and
comorbid situations, laboratory parameters such as AHI,
arousal index, and changes in blood oxygen saturation
were found to be related with frequency of nocturia in
OSA (6,8,10,16–18).
The effect of age on the frequency of nocturia is well
known. The prevalence of nocturia in the population
increases from 10% in a young population up to 64%–80%
in the elderly (16,19–20). Likewise, aging is also related to
OSA, whereby the diagnosis of OSA peaks between the
fourth and sixth decades (6,20). Similarly, the majority of
our patients (60.8%) were between 45 and 64 years of age,
and 42.6% of them were diagnosed to have severe OSA.
Moreover, the percentage of patients who had a nocturia
frequency of ≥4 was significantly higher in patients
between 45 and 64 years of age. In our study, logistic
regression analysis showed that aging increases nocturia
frequency by 2.1%.
Obesity is a known risk factor for OSA and the
prevalence of nocturia increases among obese and morbidly
obese patients. In the literature there are studies reporting
an association between obesity and increased frequency
of nocturia in patients with OSA (12,13,16,18). In our
study, although patients with moderate and severe OSA
had increased body mass index and neck circumferences,

we failed to demonstrate any effect of these parameters on
the frequency of nocturia. This may be due to the fact that
our patient population was a rather homogeneous group
with regard to body mass index and neck circumference.
Therefore, when there are no extreme values (i.e. morbidly
obese patients), the effect will probably be subtle.
When we examined the PSG parameters we found
that AHI and average oxygen saturation, which are the
indicators of apnea and hypoxia, were independent
variables affecting nocturia frequency. Several mechanisms
take part in the occurrence of nocturia in patients with
OSA (10,18). Repetitive episodes of hypoxia during apnea
and alterations in intrapleural negative pressure will affect
the right atrium, resulting in increased atrial natriuretic
peptide (ANP) secretion. Increased levels of ANP will
result in inhibition of the renin–angiotensin–aldosterone
system, eventually causing increased sodium and urine
excretion (21–23). Furthermore, increased sympathetic
activity in OSA patients causes increased urine production
and hyperactivity of bladder smooth musculature (10).
OSA may coexist with COPD, diabetes mellitus,
hypertension,
coronary
artery
disease,
and
monosymptomatic enuresis nocturia in children (18,24).
Moreover it has been reported that OSA is associated
with lower urinary tract symptoms and a significant
improvement of symptoms can be achieved when OSA is
treated (25). The coexistence of COPD and OSA is very
common, due to the same risk factors underlying these 2
clinical entities. Nocturia is frequently seen in COPD cases
due to hypoxia, frequent awakenings, and anticholinergic
medication. In our study we found that OSA patients
having these conditions had increased nocturia prevalence;
however, in logistic regression analysis only hypertension,
diabetes mellitus, and COPD were found to be risk factors
affecting the frequency of nocturia.
In conclusion, nocturia is closely associated with
OSA. The frequency of nocturia per night increases as
the severity of OSA increases. The increased prevalence
of nocturia in OSA, diabetes mellitus, hypertension, and
COPD indicates the complex physiological background
of this bothersome urologic symptom. Therefore, when
evaluating a patient for nocturia, these associated factors
should be kept in mind. A better understanding of nocturia
and its association with different clinical conditions
would help clinicians to tailor an individualized approach
according to the patient’s condition.
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